Capital Fund Management (CFM)’s Insmed INSM Stock Holding History

Capital Fund Management (CFM)’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.34M	Sell	20,400 -400	-2%	-$61.5K	0.02%	1104
2025 Q4	$3.62M	Buy	+20,800	New	+$3.8M	0.01%	1366

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital Fund Management (CFM)'s INSM Position: Q3 2024 in Review

Capital Fund Management (CFM) sold out of Insmed (INSM) in Q3 2024, closing a stake of 31,161 shares — an estimated $2.09M sold.

Capital Fund Management (CFM) first reported a position in INSM in Q3 2022 and held it in 2 quarters. The position peaked at $2.09M in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

Capital Fund Management (CFM) reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
Capital Fund Management (CFM) sold 31,161 Insmed shares in Q3 2024, an estimated $2.09M.
Capital Fund Management (CFM) first reported a position in Insmed in Q3 2022 and held it in 2 quarters.
Capital Fund Management (CFM)'s Insmed position peaked at $2.09M in Q2 2024.
413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2024, filed 13 Nov 2024.